Considering that one hallmark of cancer cells is the ability to evade immune surveillance [90] and that one contribution of senescent cells is to interact with immune cells to promote the immunoclearance effect of tumor cells [91], it is valuable to explore whether anti‐tumor immune response increases upon CDK16 KD. This evidence concerns the gene CDK16 and cancer.